GF
GBT

Gabelli Funds’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Gabelli Funds’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-432,378
Closed -$29.4M – 1395
2022
Q3 		$29.4M Buy
432,378
+413,178
+2,152% +$22.8M 0.24% 114
2022
Q2 		$613K Buy
19,200
+200
+1% +$5.86K ﹤0.01% 966
2022
Q1 		$658K Hold
19,000
– – ﹤0.01% 991
2021
Q4 		$556K Sell
19,000
-8,824
-32% -$273K ﹤0.01% 1041
2021
Q3 		$709K Sell
27,824
-19,000
-41% -$558K ﹤0.01% 984
2021
Q2 		$1.64M Buy
46,824
+20,500
+78% +$800K 0.01% 799
2021
Q1 		$1.07M Buy
+26,324
New +$1.21M 0.01% 878
2019
Q4 		– Sell
-12,000
Closed -$582K – 1146
2019
Q3 		$582K Hold
12,000
– – ﹤0.01% 939
2019
Q2 		$631K Hold
12,000
– – ﹤0.01% 959
2019
Q1 		$635K Hold
12,000
– – ﹤0.01% 944
2018
Q4 		$493K Sell
12,000
-2,000
-14% -$74.9K ﹤0.01% 970
2018
Q3 		$532K Buy
14,000
+2,500
+22% +$111K ﹤0.01% 1001
2018
Q2 		$520K Buy
11,500
+4,500
+64% +$205K ﹤0.01% 999
2018
Q1 		$338K Buy
+7,000
New +$390K ﹤0.01% 1050

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli Funds's GBT Position: Q4 2022 in Review

Gabelli Funds sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 432,378 shares — an estimated $29.4M sold.

Gabelli Funds first reported a position in GBT in Q1 2018 and held it in 14 quarters. The position peaked at $29.4M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Gabelli Funds reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Gabelli Funds sold 432,378 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $29.4M.
  • Gabelli Funds first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 14 quarters.
  • Gabelli Funds's Global Blood Therapeutics, Inc. position peaked at $29.4M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Gabelli Funds's 13F filing for Q4 2022, filed 13 Feb 2023.